These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22095961)

  • 1. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
    Hu LS; Eschbacher JM; Dueck AC; Heiserman JE; Liu S; Karis JP; Smith KA; Shapiro WR; Pinnaduwage DS; Coons SW; Nakaji P; Debbins J; Feuerstein BG; Baxter LC
    AJNR Am J Neuroradiol; 2012 Jan; 33(1):69-76. PubMed ID: 22095961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas.
    Hilario A; Ramos A; Perez-Nuñez A; Salvador E; Millan JM; Lagares A; Sepulveda JM; Gonzalez-Leon P; Hernandez-Lain A; Ricoy JR
    AJNR Am J Neuroradiol; 2012 Apr; 33(4):701-7. PubMed ID: 22207304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.
    Sadeghi N; D'Haene N; Decaestecker C; Levivier M; Metens T; Maris C; Wikler D; Baleriaux D; Salmon I; Goldman S
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):476-82. PubMed ID: 18079184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z; You RX; Li J; Liu Y; Cao DR
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.
    Hu LS; Baxter LC; Pinnaduwage DS; Paine TL; Karis JP; Feuerstein BG; Schmainda KM; Dueck AC; Debbins J; Smith KA; Nakaji P; Eschbacher JM; Coons SW; Heiserman JE
    AJNR Am J Neuroradiol; 2010 Jan; 31(1):40-8. PubMed ID: 19749223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
    Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
    Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion imaging of brain gliomas using arterial spin labeling: correlation with histopathological vascular density in MRI-guided biopsies.
    Ningning D; Haopeng P; Xuefei D; Wenna C; Yan R; Jingsong W; Chengjun Y; Zhenwei Y; Xiaoyuan F
    Neuroradiology; 2017 Jan; 59(1):51-59. PubMed ID: 27924360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Yang S; Babb JS; Knopp EA; Golfinos JG; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2004 May; 25(5):746-55. PubMed ID: 15140713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.
    Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG
    AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.
    Álvarez-Torres MDM; Fuster-García E; Juan-Albarracín J; Reynés G; Aparici-Robles F; Ferrer-Lozano J; García-Gómez JM
    BMC Cancer; 2022 Jan; 22(1):40. PubMed ID: 34991512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
    Soliman RK; Gamal SA; Essa AA; Othman MH
    Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.
    Di Stefano AL; Bergsland N; Berzero G; Farina L; Rognone E; Gastaldi M; Aquino D; Frati A; Tomasello F; Ceroni M; Marchioni E; Bastianello S
    Biomed Res Int; 2014; 2014():154350. PubMed ID: 24800207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading.
    Kang HY; Xiao HL; Chen JH; Tan Y; Chen X; Xie T; Fang JQ; Wang S; Yang Y; Zhang WG
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):51-7. PubMed ID: 26381565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.
    Chaskis C; Stadnik T; Michotte A; Van Rompaey K; D'Haens J
    Acta Neurochir (Wien); 2006 Mar; 148(3):277-85; discussion 285. PubMed ID: 16421765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion MRI as a neurosurgical tool for improved targeting in stereotactic tumor biopsies.
    Lefranc M; Monet P; Desenclos C; Peltier J; Fichten A; Toussaint P; Sevestre H; Deramond H; Le Gars D
    Stereotact Funct Neurosurg; 2012; 90(4):240-7. PubMed ID: 22699810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.